Viewing nowNellastone 20 mg (Rosuvastatin Calcium)
Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Korea Nelson Pharmaceutical Co., Ltd.

MFDS item code 202003263 · Approved 2020.05.04 · Insurance code 656702110
Improvement of dyslipidemia, reduction of cardiovascular disease risk, and inhibition of atherosclerosis progression
This medication is used as an adjunctive therapy in patients with hyperlipidemia, including primary hypercholesterolemia and heterozygous familial hypercholesterolemia, when diet and exercise alone do not adequately control cholesterol levels. Additionally, it serves as an adjunct therapy to diet or other lipid-lowering treatments in patients with homozygous familial hypercholesterolemia. This medication lowers total cholesterol and LDL cholesterol levels, delaying the progression of atherosclerosis and protecting cardiovascular health. It is also effective in reducing cholesterol levels in pediatric patients aged 10 to 17 with heterozygous familial hypercholesterolemia. It is used as an adjunct to diet in patients with primary dysbetalipoproteinemia. Particularly in adult patients at high risk for cardiovascular disease, it helps to reduce the risk of stroke, myocardial infarction, and arterial revascularization. Therefore, this medication is effectively used for various types of hypercholesterolemia and cardiovascular risk reduction.
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine, and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which is sufficient for most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response, and may be increased up to a maximum of 20 milligrams daily. 3. Elderly patients: No dose adjustment is necessary. 4. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering 20mg of this medicine to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 6. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose is contraindicated in some of these patients.
2. Pediatric patients with heterozygous familial hypercholesterolemia (ages 10 ~ 17): The usual dose range is 5 milligrams ~ 20 milligrams once daily. (There are no clinical data on doses higher than 20 milligrams in pediatric patients.) The dose should be adjusted at intervals of 4 weeks or longer. Children under 10 years of age: Safety and efficacy have not been established.
This medication should not be used in certain patients. For instance, patients who are allergic to this medication, have severe liver dysfunction, have muscle disorders, have significantly impaired kidney function, or are pregnant or breastfeeding should not take this medication. Additionally, this medication may affect muscles, so caution is required in patients at risk for muscle pain or severe muscle damage. In such cases, it is important to regularly check muscle status through blood tests. Patients with liver function issues or those who consume high amounts of alcohol also need to undergo frequent liver function tests while taking this medication. Patients with conditions such as hypothyroidism or nephrotic syndrome should first treat these conditions before taking this medication. This medication can interact with other drugs; therefore, consultation with a healthcare professional is necessary, especially when taking certain antivirals, immunosuppressants, antibiotics, and fibrate medications. Concomitant use with certain drugs may increase the blood concentration of this medication and raise the risk of side effects. Women with the possibility of pregnancy must use effective contraception and should not take this medication during pregnancy. Additionally, breastfeeding women should avoid this medication. During the course of taking this medication, if symptoms such as muscle pain, muscle weakness, dizziness, or liver function abnormalities occur, they should immediately inform healthcare personnel. If there are severe skin reactions or allergic symptoms, the medication should be discontinued immediately, and medical advice should be sought. In cases of overdose, there are no specific antidotes, and treatment should be symptom-driven with monitoring of liver function and muscle enzymes. Caution is advised when driving or operating machinery, as dizziness may occur. Lastly, this medication may exhibit higher blood concentrations in Asians, so dosage adjustments may be necessary.
Hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, memory loss, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, oculomotor weakness, thrombocytopenia, jaundice, hepatitis, elevated transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome, lichenoid drug eruption, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, elevated ALT, chest pain, muscle cramps, gout, erectile dysfunction, fatigue, numbness, paresthesia, chest discomfort, loss of appetite, abdominal distension, syncope, generalized pain
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture, and it is recommended to keep it at room temperature between 1 to 30 degrees Celsius. Proper storage will help maintain the effectiveness of the medication and ensure safe usage.
Pink, round film-coated tablets
100 tablets/bottle, 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Korea Nelson Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.